Insider Selling: Addus HomeCare (NASDAQ:ADUS) EVP Sells 592 Shares of Stock

Addus HomeCare Corporation (NASDAQ:ADUS) EVP Michael Wattenbarger sold 592 shares of the firm’s stock in a transaction that occurred on Tuesday, February 24th. The stock was sold at an average price of $107.35, for a total value of $63,551.20. Following the sale, the executive vice president directly owned 9,744 shares of the company’s stock, valued at $1,046,018.40. This represents a 5.73% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Addus HomeCare Trading Down 3.3%

ADUS traded down $3.58 during trading on Thursday, hitting $104.02. The company’s stock had a trading volume of 269,378 shares, compared to its average volume of 239,147. Addus HomeCare Corporation has a twelve month low of $88.96 and a twelve month high of $124.43. The company has a quick ratio of 1.66, a current ratio of 1.80 and a debt-to-equity ratio of 0.11. The stock’s fifty day moving average price is $109.57 and its 200-day moving average price is $113.08. The firm has a market capitalization of $1.92 billion, a P/E ratio of 19.97, a PEG ratio of 1.26 and a beta of 0.91.

Key Stories Impacting Addus HomeCare

Here are the key news stories impacting Addus HomeCare this week:

• Positive Sentiment: Q4 earnings/earnings call emphasized continued revenue growth, margin-leverage opportunities and an M&A-driven growth strategy for 2026 — supports longer‑term earnings upside. Addus HomeCare Earnings Call Highlights Growth And Scale
• Positive Sentiment: Stephens trimmed its price target from $140 to $135 but kept an “overweight” rating — the new target implies meaningful upside from current levels, indicating analyst confidence in the company’s outlook despite the cut. Stephens price target note
• Neutral Sentiment: Addus will participate in the Raymond James Institutional Investors Conference (investor visibility event; typically neutral but can aid liquidity/coverage). Conference participation
• Neutral Sentiment: Some published short‑interest data in the feed shows zero shares (data glitch/inconsistent reporting across sources) — treat those specific zero figures with caution. MarketBeat ADUS page
• Negative Sentiment: Significant insider selling over Feb. 24–25: CEO R. Dirk Allison sold two blocks (4,988 and 2,364 shares) and multiple senior EVPs sold smaller blocks across the two days — coordinated insider sales can pressure sentiment even if individual sales are routine and pre‑planned. See CEO filing. CEO insider-sale SEC filing
• Negative Sentiment: Short interest rose earlier in February (as of Feb. 13 there were ~1.15M shares short, ~6.5% of shares outstanding and ~4.6 days‑to‑cover) — elevated short activity can amplify downward price moves. Short interest data

Analyst Upgrades and Downgrades

A number of research firms have commented on ADUS. Truist Financial set a $135.00 price target on shares of Addus HomeCare and gave the stock a “buy” rating in a report on Wednesday, January 7th. Wall Street Zen upgraded Addus HomeCare from a “buy” rating to a “strong-buy” rating in a report on Monday. BMO Capital Markets initiated coverage on Addus HomeCare in a research note on Thursday, November 13th. They issued a “market perform” rating and a $120.00 price objective for the company. Royal Bank Of Canada restated an “outperform” rating and set a $139.00 price objective on shares of Addus HomeCare in a report on Wednesday. Finally, Stephens cut their target price on Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating on the stock in a report on Wednesday. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $134.33.

Institutional Trading of Addus HomeCare

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in ADUS. Global Retirement Partners LLC boosted its position in Addus HomeCare by 395.7% in the fourth quarter. Global Retirement Partners LLC now owns 233 shares of the company’s stock worth $25,000 after purchasing an additional 186 shares during the last quarter. Larson Financial Group LLC increased its position in shares of Addus HomeCare by 133.3% during the 3rd quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock valued at $28,000 after purchasing an additional 136 shares during the last quarter. Acumen Wealth Advisors LLC bought a new stake in shares of Addus HomeCare during the 4th quarter worth $29,000. Arax Advisory Partners raised its stake in shares of Addus HomeCare by 95.8% during the 4th quarter. Arax Advisory Partners now owns 280 shares of the company’s stock worth $30,000 after purchasing an additional 137 shares during the period. Finally, Private Trust Co. NA boosted its holdings in shares of Addus HomeCare by 65.5% in the 4th quarter. Private Trust Co. NA now owns 283 shares of the company’s stock worth $30,000 after buying an additional 112 shares during the last quarter. 95.35% of the stock is owned by institutional investors.

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.